Ngā hua rapu - Angela D’Angelo
- E whakaatu ana i te 1 - 20 hua o te 22
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlle... mā Giuseppe, Derosa, Angela, D’Angelo, Davide, Romano, Pamela, Maffioli
I whakaputaina 2017Text -
4
Evaluation of the Effects of Mesoglycan on Some Markers of Endothelial Damage and Walking Distance in Diabetic Patients with Peripheral Arterial Disease mā Giuseppe, Derosa, Angela, D’Angelo, Romano, Davide, Pamela, Maffioli
I whakaputaina 2017Text -
5
A role for quercetin in coronavirus disease 2019 (COVID‐19) mā Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, Francesco Di Pierro
I whakaputaina 2020Revisão -
6
-
7
-
8
-
9
-
10
Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers mā Valeria Brazzelli, Pamela Maffioli, Vittorio Bolcato, Christian Ciolfi, Angela D’Angelo, Carmine Tinelli, Giuseppe Derosa
I whakaputaina 2021Artigo -
11
Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men mā Colomba Falcone, Enzo Emanuele, Angela D’Angelo, Maria Paola Buzzi, Chiara Belvito, Mariaclara Cuccia, Diego Geroldi
I whakaputaina 2005Artigo -
12
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells mā Valentina Masola, Giovanni Gambaro, Elena Tibaldi, Anna Maria Brunati, Alessandra Gastaldello, Angela D’Angelo, Maurizio Onisto, Antonio Lupo
I whakaputaina 2011Artigo -
13
Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis mā Sandro Giannini, M. Nobile, Leonardo Sartori, Luca Dalle Carbonare, Matteo Ciuffreda, Paolo Corrò, Angela D'Angelo, Lorenzo A. Calò, Gaetano Crepaldi
I whakaputaina 1999Artigo -
14
Galectin-3 Plasma Levels and Coronary Artery Disease: A New Possible Biomarker of Acute Coronary Syndrome mā Colomba Falcone, Simona Lucibello, Iolanda Mazzucchelli, Sara Bozzinì, Angela D’Angelo, Sandra Schirinzi, Rossana Totaro, Rossana Falcone, M. Bondesan, Gabriele Pelissero
I whakaputaina 2011Artigo -
15
Effects of dietary protein and phosphorus restriction on the progression of early renal failure mā Giuseppe Maschio, Lamberto Oldrizzi, Nicola Tessitore, Angela D’Angelo, E. Valvo, Antonio Lupo, C. Loschiavo, Antonia Fabris, Linda Gammaro, Carlo Rugiu, Giovanni Panzetta
I whakaputaina 1982Artigo -
16
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients mā Sandro Giannini, Angela D’Angelo, Gianni Carraro, M. Nobile, Paolo Rigotti, Luciana Bonfante, Francesco Marchini, Martina Zaninotto, Luca Dalle Carbonare, Leonardo Sartori, G Crepaldi
I whakaputaina 2001Artigo -
17
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone mā Giuseppe Derosa, Elena Fogari, Angela D’Angelo, Arrigo F.G. Cicero, Sibilla Salvadeo, P. D. Ragonesi, Ilaria Ferrari, Alessia Gravina, Raffaella Fassi, Roberto Fogari
I whakaputaina 2007Artigo -
18
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial mā Giuseppe Derosa, Luigina Guasti, Angela D’Angelo, Chiara Martinotti, Maria Chiara Valentino, Sergio Di Matteo, Giacomo Matteo Bruno, Andrea Maria Maresca, Giovanni Gaudio, Pamela Maffioli
I whakaputaina 2022Artigo -
19
Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA. mā Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo, Pietro D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Ilaria Ferrari, Alessia Gravina, Roberto Fogari
I whakaputaina 2006Artigo -
20
Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome mā Giuseppe Derosa, Angela D’Angelo, P. D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Lorenza Montagna, Alessia Gravina, Ilaria Ferrari, S. Paniga, Arrigo F.G. Cicero
I whakaputaina 2006Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Biochemistry
Body mass index
Chemistry
Gastroenterology
Pathology
Biology
Insulin resistance
Alternative medicine
Antioxidant
Blood pressure
Calcium
Creatinine
Disease
Insulin
Placebo
Resistin
Rosiglitazone
Adipokine
Adiponectin
Cardiology
Coronary artery disease
Gene
Irbesartan
Lipid profile
Metabolic syndrome